Ritter Daniher Financial Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35
| Closed | -$24.9K | – | 327 |
|
|
2024
Q4 | $24.9K | Sell |
35
-4
| -10% | -$2.85K | 0.01% | 199 |
|
|
2024
Q3 | $41K | Hold |
39
| – | – | 0.01% | 174 |
|
|
2024
Q2 | $41K | Hold |
39
| – | – | 0.01% | 165 |
|
|
2024
Q1 | $37.5K | Sell |
39
-19
| -33% | -$18.3K | 0.01% | 169 |
|
|
2023
Q4 | $50.9K | Hold |
58
| – | – | 0.02% | 149 |
|
|
2023
Q3 | $47.7K | Hold |
58
| – | – | 0.02% | 145 |
|
|
2023
Q2 | $41.7K | Hold |
58
| – | – | 0.02% | 148 |
|
|
2023
Q1 | $47.7K | Sell |
58
-7
| -11% | -$5.75K | 0.02% | 140 |
|
|
2022
Q4 | $46.9K | Buy |
+65
| New | +$46.9K | 0.02% | 150 |
|